PEPTIDREAM INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,622 JPY | +1.66% |
|
+10.45% | +9.12% |
| Sales 2024 * | 34.39B 219M 17.5B | Sales 2025 * | 38.78B 247M 19.73B | Capitalization | 210B 1.34B 107B |
|---|---|---|---|---|---|
| Net income 2024 * | 7.03B 44.86M 3.58B | Net income 2025 * | 9.13B 58.22M 4.64B | EV / Sales 2024 * | 5.81 x |
| Net cash position 2024 * | 10.43B 66.53M 5.31B | Net cash position 2025 * | 21B 134M 10.69B | EV / Sales 2025 * | 4.88 x |
| P/E ratio 2024 * |
29.9
x | P/E ratio 2025 * |
23
x | Employees | 603 |
| Yield 2024 * |
-
| Yield 2025 * |
0.12% | Free-Float | 73.93% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | +1.66% | ||
| 1 week | +10.45% | ||
| Current month | +13.94% | ||
| 1 month | +14.83% | ||
| 3 months | +21.77% | ||
| 6 months | +47.05% | ||
| Current year | +9.12% |
1 week
1 564.50
1 650.50
1 month
1 420.501 650.50
Current year
1 224.501 650.50
1 year
1 039.002 549.00
3 years
1 039.005 560.00
5 years
1 039.006 540.00
10 years
646.256 540.00
| Managers | Title | Age | Since |
|---|---|---|---|
Patrick Reid
CEO | Chief Executive Officer | 49 | 31/12/06 |
| Director of Finance/CFO | 46 | 31/12/17 | |
Keiichi Masuya
COO | Chief Operating Officer | 55 | 30/06/14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Patrick Reid
CEO | Chief Executive Officer | 49 | 31/12/06 |
Michio Sasaoka
BRD | Director/Board Member | 74 | 30/04/12 |
Junko Morita
BRD | Director/Board Member | 52 | 28/02/21 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.03% | 16 M€ | -7.06% | ||
| 0.54% | 15 M€ | +7.34% | ||
| 0.06% | 14 M€ | +15.63% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 1,622 | +1.66% | 856,100 |
| 25/04/24 | 1,596 | -1.08% | 828,200 |
| 24/04/24 | 1,613 | -0.55% | 1,043,200 |
| 23/04/24 | 1,622 | +6.89% | 1,230,200 |
| 22/04/24 | 1,518 | +3.34% | 449,900 |
Delayed Quote Japan Exchange, April 26, 2024 at 07:00 am
More quotes
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Calendar
13/05/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,622
JPY
Average target price
2,667
JPY
Spread / Average Target
+64.41%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.12% | 1.34B | |
| -2.43% | 103B | |
| +1.35% | 95.28B | |
| +1.66% | 22.15B | |
| -15.56% | 21.02B | |
| -8.38% | 18.15B | |
| -41.01% | 16.73B | |
| -13.43% | 16.05B | |
| +4.07% | 13.68B | |
| +34.72% | 12.17B |
- Stock Market
- Equities
- 4587 Stock
